Open AccessClinical and functional recovery in a patient with pulmonary hypertension after bariatric surgery
Author(s) -
Rahul Karna,
Rahat Hussain,
Soma Jyothula
Publication year - 2021
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_76_21
Subject(s) - medicine , pulmonary hypertension , tadalafil , ambrisentan , weight loss , medical therapy , obstructive sleep apnea , pulmonary function testing , treprostinil , surgery , obesity , intensive care medicine , endothelin receptor , bosentan , erectile dysfunction , receptor
Severe pulmonary hypertension (PH) in obese patients pose a challenge to treat despite advances in medical therapeutics. Current treatment options are limited for patients who are not responding to maximal medical therapy. Here, we present a case of multifactorial PH, not responsive to ambrisentan, tadalafil, and treprostinil, even after optimization of cardiac and pulmonary function and had a poor prognosis. She demonstrated weight loss after bariatric surgery, improving her restrictive lung disease, obstructive sleep apnea and PH, and overall functionality. Bariatric surgery may offer a potential therapeutic option, in patients with morbid obesity and PH resistant to maximal medical therapy.